For the latest COVID-19 (Coronavirus) information: CCTG public updates | CCTG member information

Group newsletter: CCTG Connection

Archived Bulletins

March 18, 2020

Published: March 18, 2020
Category: Office of the Director
CCTG Spring meeting update on coronavirus (COVID-19)

CCTG has continued to monitor the developments pertaining to the coronavirus (COVID-19). 

Read More

March 13, 2020

Published: March 13, 2020
Category: Group updates

CCTG has continued to monitor the developments pertaining to the coronavirus (COVID-19).  After careful consideration and evaluation of available information at this time, and out of an abundance of caution for the entire network, the CCTG Annual Spring Meeting for 2020 is cancelled.

Read More

March 10, 2020

Published: March 10, 2020
Category: CCTG Bulletin

CCTG Network Members,

CCTG is actively monitoring the continuing developments pertaining to the coronavirus (COVID-19) .  This includes reviewing reliable sources of information nationally and internationally as well as tracking travel restrictions.  We are evaluating risks to patient safety, trial conduct and integrity, as well as critical meetings and engagement activities across the network.  Safety and security are our top priorities as we review the situation. 

Read More

March 04, 2020

Published: March 04, 2020
Category: Trials

The purpose of this study was to find the highest dose of durvalumab or of durvalumab with tremelimumab that can be tolerated without causing very severe side effects when receiving standard chemotherapy and to see what effects the study drugs has on this type of cancer.

Read More

Published: March 04, 2020
Category: Trials

Trial closures for BR16 (NCT00008385) trial: Phase III Chemoprevention Trial of Selenium Supplementation in Persons With Resected Stage 1 Non-Small Cell Lung Cancer and IND222 ( NCT02619864) A Phase I Study of the mTORC1/mTORC2 Kinase Inhibitor AZD2014 in Patients with Previously Treated Glioblastoma Multiforme.

Read More

February 19, 2020

Published: February 19, 2020
Category: Group updates
 CCTG Annual Spring Meeting

The CCTG Annual Spring Meeting of Participants is almost here, if you are planning meetings and/or attending the Spring Meeting here is some information you should know!

Read More

Published: February 19, 2020
Category: Group updates
Frances A Shepherd Award

Applicants who have had their research accepted for oral or poster presentation at an international scientific meeting and have not received another award to support their travel are eligible to apply.

Spring application deadline is March 27, 2020

Read More

Published: February 19, 2020
Category: News

CCTG Patient Representative Bob Taylor discusses the importance of having somebody, that's not the clinical researcher, representing what patients care about and considering the interests of the patients and their family in clinical trial design.

Read More